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A Randomised Prospective Trial 
S. J. Fearn ~, A. D. Parry, A. J. Picton, A. J. Mortimer and C. N. McCollum 
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Objective: To investigate whether heparin reversal after carotid endarterectomy reduces the incidence of haemorrhagic 
complications. 
Design: A randomised prospective trial. 
Methods: Sixty-four patients randomised toreversal of heparin or no reversal, of whom 31 received protamine titrated 
to the residual circulating heparin at closure of arteriotomy. Measurements included serial activated clotting times 
(ACTs), wound drainage, neck swelling using duplex Doppler imaging to measure the depth from skin to carotid 
bifurcation, and the recording of all complications. 
Results: Wound rainage volumes were signifi'cantly reduced by protamine r versal (68.5 ml compared to35 mI, p<O.O01), 
but neck swelling was not (72 mm compared to 70 mm, p =0.77). Two patients who were not reversed eveloped neck 
haematomas requiring evacuation. More importantly, two patients receiving protamine, thrombosed the operated internal 
carotid artery (ICA) postoperatively and died despite urgent hrombectomy. A further patient who was not randomised 
in this study but who received protamine also developed ICA thrombosis within the same 3 month period. 
Conclusions: Reversing heparin with protamine reduces postoperative wound drainage after carotid surgery but may 
predispose toICA thrombosis and stroke. This is in keeping with a previous retrospective study published uring our 
triaI. 7 
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Introduction 
The role of carotid endarterectomy in preventing 
stroke in symptomatic patients with severe internal 
carotid artery (ICA) stenosis is now established, m To 
reduce the risk of thromboembolic events, aspirin is 
prescribed preoperatively and heparin is administered 
prior to cross-clamping. 3 The combination of aspirin 
and heparin may contribute to the risk of postoperative 
hemorrhage or wound haematoma which are re- 
cognised complications occurring in 4-6.5% of 
patients. 4'5 Severe haematomas occasionally precipitate 
tracheal deviation, stridor and respiratory distress, 
necessitating urgent re-exploration of the neck. In such 
cases, tracheal intubation can be difficult and ventil- 
atory support in intensive care may even be required. 
Protamine has been widely used in the U.S.A. to 
reverse heparin after carotid endarterectomy, but is 
used by only 26% of surgeons of the European Society 
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for Vascular Surgery. 6 The incidence of haematoma in
those receiving protamine was reported in retro- 
spective studies to be 1.2% compared to 6.2% without 
protamine. 5 There was clearly a need for a prospective 
clinical trial which we initiated with a plan to recruit 
200 patients, but when two patients who had received 
protamine died of postoperative stroke in the context 
of a stroke rate of 1.6% without the routine use of 
protamine prior to starting this study, the study was 
terminated and the data analysed. Our decision to 
terminate was assisted by a further stroke in a patient 
not randomised in this study but given protamine, 
and by the publication at that time of a retrospective 
review of 348 carotid endarterectomies which reported 
an increased incidence of perioperative stroke in 
patients receiving protamine7 
As far as we are aware, there have not been any 
prospective randomised trials on this topic. 
Methods 
This trial was approved by the Medical Research 
Ethical Committee with informed consent in writing 
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Fig. 1. Example heparin dose-response curve. ACT was measured 
at baseline, post heparin and again at closure of arteriotomy. The 
latter could then be extrapolated to etermine the amount of residual 
circulating heparin for reversal. 
from all patients. Sixty-three patients undergoing ca- 
rotid endarterectomy for severe internal carotid artery 
stenosis under the care of one consultant surgeon, were 
randomised to either protamine reversal of heparin or 
no reversal. 
Patients were excluded if they had a history of 
allergy to heparin, protamine sulphate, or fish, if they 
had insulin dependent diabetes mellitus or were not 
taking aspirin. General anaesthesia was administered 
by the same consultant anaesthetist using isoflurane in 
50% oxygen delivered via positive pressure ventilation 
adjusted to maintain normocapnoea. Systemic blood 
pressure was measured irectly from a cannula in the 
contralateral radial artery. The depth of anaesthesia 
was adjusted intraoperatively to maintain blood pres- 
sure as near as possible to preoperative values. 
Serial activated clotting times (ACTs) were mon- 
itored using a Medtronic Haemotec Automated Co- 
agulation Timer (Colorado). Two samples were taken 
at each time interval and if similar, a mean result was 
calculated. An initial ACT served as a baseline, prior 
to bolus administration of 70 iu /kg of heparin before 
carotid cross-clamps were applied. A second ACT was 
then taken three minutes later enabling a heparin 
dose-response curve to be plotted 8 (Fig. 1). If this 
value was within 2-2.5 times the normal range it was 
deemed acceptable. If not, further heparin was given 
according to the individual patient's dose response 
curve. On declamping, after endarterectomy, a further 
ACT was taken to calculate the residual circulating 
heparin which in the appropriately randomised 
patients, was then reversed with protamine sulphate 
given slowly, intravenously at a dose of 1 rag/100 iu 
heparin. This is a lower dose than that recommended 
Table 1. Operative techniques. 
Procedure Protamine Controls 
n =31 n=33 
Primary closure 27 18 
Patch angioplasty 3 4 
Reimplantation 1 5 
Prosthetic graft replacement 0 6 
Shunted 2 8 
for complete reversal of heparin in patients undergoing 
cardiopulmonary b pass (up to 2 mg/100 iu). A final 
ACT was taken 3 min after protamine administration. 
In all cases a vacuum wound drain was inserted and 
manual pressure applied to the wound during, and 
for 5 min after reversal of anaesthesia. Peroperative 
monitoring of ipsilateral cerebral oxygen saturation 
and middle cerebral artery blood flow, using near- 
infrared spectroscopy and transcranial Doppler ultra- 
sonography respectively, was carried out in all 
patients. Shunting was instituted if middle cerebral 
flow velocity fell by 80% and/or  cerebral oxygen 
saturation fell by 10% or more. These are criteria which 
we have developed over 4 years of research in this 
area. 9'1° Dacron patch angioplasty was carried out for 
all internal carotid arteries with an external diameter 
of less than 5 mm. Dilated or tortuous arteries were 
reimplanted or replaced with prosthetic graft. 
All patients received perioperative aspirin. Neither 
heparin nor protamine were given postoperatively. 
Neck swelling was assessed preoperatively and 2 days 
postoperatively using duplex Doppler imaging to 
measure the depth of the carotid bifurcation from the 
skin surface. Wound drainage volumes were measured 
daily and removed when drainage in any 24 h period 
fell to 50 ml or less. Statistical analysis utilised Fisher's 
exact test, and the Mann Whitney U-test for non- 
parametric data. 
Results 
Sixty-three patients were randomised, one of whom 
underwent bilateral endarterectomy separated by 2 
months, giving a total of 64 randomisation episodes 
over an 11 month period during 1994-1995. Seventy 
percent of the endarterectomies were closed primarily, 
the rest involved patch angioplasty, reimplantation 
or prosthetic graft replacement (Table 1). Ten (16%) 
procedures involved an intraluminal shunt. 
There were 39 men and 24 women with an average 
age of 66 years (range 48-85). Thirty-one patients (48%) 
received protamine. The mean doses of heparin and 
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Fig. 2. Trend of median ACT (interquartile range) throughout carotid 
endarterectomy. 
protamine administered were 5200iu (range 3500- 
7000) and 33mg (range 20-64) respectively. Eight 
(12.5%) patients had a baseline ACT below the normal 
range (90-120 s); in 50% of these cases the heparin was 
reversed with protamine, but none developed ICA 
thrombosis. Two patients required further heparin to 
bring their ACT within range (1350 and 2000 iu). 
Median change in ACT in the two groups during 
the procedure is shown in Fig. 2. Median drain vol- 
umes were 68.5 ml (interquartile range 41-128) in the 
control group compared to 35 ml (25--46) when prot- 
amine was given (p<0.001, Mann Whitney U- test Fig 
3). 
Median percentage change in depth to carotid bi- 
furcation from the skin surface measured by Duplex 
scan was not significantly different between the two 
groups; 73 mm in the reversed group compared to 
72 mm in the controls (p =0.77). 
Two patients who did not receive protamine had to 
return to theatre for evacuation of neck haematomas 
where generalised oozing was discovered rather than 
a specific arterial bleeding point. Both patients re- 
turned to the ward from theatre and made an un- 
eventful recovery. There were no haematomas when 
heparin had been reversed. More importantly, two 
patients given protamine developed ICA thrombosis 
within 12 h of surgery. Despite urgent hrombectomy 
and patch angioplasty, neither patient recovered from 
coma postoperatively and support systems were even- 
tually discontinued. Both had routine carotid en- 
darterectomies with simple closure and did not require 
an intraluminal shunt due to acceptable values of 
cerebral oxygen saturation and middle cerebral artery 
blood flow despite contralateral ICA occlusions. The 
first, a 66-year-old lady developed contralateral hemi- 
paresis 12 h postoperatively. The second, aged 64 years, 
experienced severe hyperperfusion lasting several 
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Fig. 3. Drain volumes and median values (interquartile range) for 
patients receiving protamine and controls. 
minutes following carotid clamp removal during 
which her middle cerebral artery blood velocity in- 
creased by more than 200%. She had no neurological 
symptoms in the recovery room but was treated with 
mannitol and dexamethasone prophylactically. Several 
hours later she demonstrated signs of cerebral ir- 
ritation which rapidly progressed to hemiplegia. At 
re-exploration the ICA was full of platelet hrombus 
firmly adherent to the endarterectomy surface with 
no sign of dissection or intimal flaps. 
Fifty-seven patient records were available after a 
mean follow up of 4 months (range 1-12). One patient 
with atrial fibrillation had occluded his carotid Dacron 
graft, and one other had developed a 70% restenosis 
with appearances suggestive of intimal hyperplasia 
on Duplex scanning, neither had received protamine. 
There were no other significant restenoses or late 
occlusions. 
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Discussion 
The popularity of carotid endarterectomy ay increase 
further if current studies support its efficacy in the 
reduction of stroke in patients with asymptomatic 
carotid disease. Efforts to reduce the incidence of 
any complications associated with this procedure are 
therefore important and this study confirms the bene- 
ficial effects of protamine on redudng wound drainage 
postoperatively to levels which may preclude the use 
of a drain (median 35 ml). Unfortunately we felt com- 
pelled to discontinue this study before sufficient num- 
bers had been recruited to reliably investigate the 
incidence of postoperative haematoma. 
The incidence of postoperative haematoma, nd not 
stroke, was the original end-point to this study, there- 
fore our figures are too small to demonstrate a stat- 
istically significant difference in the incidence of ICA 
thrombosis when protamine is used. However, haem- 
atoma is usually not life threatening whereas troke 
is often devastating and we therefore felt the trial 
should cease. 
We were assisted in this decision by a further stroke 
in a patient who was not randomised ue to lack of 
an available coagulation timer, but was given prot- 
amine due to a growing awareness of reductions in 
wound drainage. She also developed ICA thrombosis 
after a routine carotid endarterectomy and primary 
closure. Despite urgent thrombectomy she was left 
with a mild residual hemiplegia but could mobilise 
independently on discharge 13 days after surgery. 
In isolation it is difficult to put much emphasis 
on three cases of ICA thrombosis which led to the 
discontinuation of our study. However at the time 
we faced this dilemma, a retrospective study of 348 
patients who underwent carotid endarterectomy was 
published reporting a significantly higher stroke rate 
in those patients receiving protamine. 7 Four out of five 
of the strokes that occurred in patients given protamine 
were secondary to thrombosis at the endarterectomy 
site without evidence of technical flaws. Log linear 
analysis of their data led the authors to conclude 
that the combination of shunting, no patching and 
protamine administration was the best predictor of 
stroke. They also stated the patients who had received 
protamine were younger, female and had fewer symp- 
toms although they do not state how many cases of 
ICA thrombosis occurred in women. 
The three cases of postoperative stroke secondary 
to ICA thrombosis amongst our series of patients 
receiving protamine were also women who did not 
require patch angioplasty according to the policy in 
our unit. 
A decision to use protamine to reverse the effects 
of heparin should also take into account i s well known 
side-effects; pulmonary hypertension, systemic hypo- 
tension and bradycardia, which may require further 
pharmacological manipulation. 
The use of protamine in carotid surgery may pre- 
clude the insertion of a wound drain but may be 
associated with ICA thrombosis and we feel should 
therefore be avoided. This finding has been sub- 
stantiated in another albeit retrospective trial. 7 Since 
reverting to our previous practice we have not had 
any further cases of ICA thrombosis. 
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